id
name
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2024-01-21 13:59:14
expired found date
-
created at
2024-06-20 11:03:52
updated at
2026-01-07 09:10:22
length
12
crc
2556
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
83548
mp size raw text
1615
mp inner links count
3
mp inner links status
20 (imported)
title
Leaders in Cellular Therapy | Dendreon
description
Learn how Dendreon is improving the lives of patients through our leadership in innovative science and cellular therapies.
site name
Dendreon
author
updated
2025-12-30 05:35:21
raw text
Leaders in Cellular Therapy | Dendreon Skip to content Dendreon Main Menu News Contact Us About Science and Services Show submenu Cellular Therapy Manufacturing Provenge Immunotherapy Publications Careers The future of cellular therapy, delivered We’re revolutionizing medicine through our leadership in cellular technology. Learn More Improving The Lives of Patients Through innovative science & cellular therapies At Dendreon, we have a singular purpose: improving the lives of patients through innovative science and cellular therapies. We enable the future of complex cell therapies through research, development, and strategic partnerships. By leveraging innovative science that delivers unique therapies, our work helps change lives. See What Drives Us Provenge Technology PROVENGE ® (sipuleucel-T), Dendreon’s flagship innovation, was the first FDA-approved cellular immunotherapy brought to market. This groundbreaking treatment has been received by nea...
redirect type
0 (-)
block type
0 (no issues)
detected language
1 (English)
category id
Other [en] (231)
index version
2025123101
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
1295
text words
211
text unique words
122
text lines
39
text sentences
13
text paragraphs
3
text words per sentence
16
text matched phrases
0
text matched dictionaries
0
links self subdomains
0
links other subdomains
0
links other domains
0
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
0
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
links ext klim
0
links ext generic
0
dol status
0
dol updated
2025-12-30 05:35:21
rss path
rss status
1 (priority 1 already searched, no matches found)
rss found date
-
rss size orig
0
rss items
0
rss spam phrases
0
rss detected language
0 (awaiting analysis)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
10 (sitemap found, awaiting processing)
sitemap review version
2
sitemap urls count
69
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-01-04 13:37:23
sitemap process date
-
sitemap first import date
-
sitemap last import date
-